Navigation Links
Ground Zero Pharmaceuticals, Inc. (GZP) Announces Enhanced Biosimilars and Personalized Medicine Initiatives for its Clients
Date:11/14/2012

IRVINE, Calif., Nov. 14, 2012 /PRNewswire/ -- GZP is announcing expansion of its longstanding capabilities in helping its clients develop biosimilars and drug or biologic/diagnostic device personalized medicine programs for FDA and EMA review.  New legislative initiatives in the US and subsequent regulations and guidelines have provided a number of pathways for development of biosimilars, with the associated requirements for intensive planning and execution of nonclinical and clinical programs.  GZP's CMC, pharmacology/ toxicology, clinical and regulatory experts are available to assist firms in navigating the complexities of such programs.   

GZP has been working with firms in Australasia, the US and Europe to develop and test prognostic/diagnostic devices and test methodologies, including genetic testing and identification of biomarkers, for use during clinical trials and postapproval therapy.  The selection of appropriate candidates for clinical trials, as well as for specific commercial treatments are important in the personalized medicine and reimbursement arenas.  Regulatory success can be enhanced by assuring that new clinical trial initiatives are carried through to the review and approval process and GZP works with clients to achieve this goal.

Dr. Evan B. Siegel, GZP's CEO, will be in Kuala Lumpur (November 17-22), and will be pleased to meet with interested parties by individual arrangement in Malaysia.

In 2012, GZP increased its global client base across therapeutic areas such as oncology, ophthalmology, and endocrine disease.  The firm created and submitted several INDs and facilitated many meetings and other communications with the FDA, leading to rapid movement of client programs.  GZP believes that early, frequent, targeted, and creative FDA communication leads to successful product development and attracts investors in today's financial climate.

According to Evan Siegel, "We are
'/>"/>

SOURCE Ground Zero Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. San Diego Based Neurosurgeon Offers Groundbreaking Treatment to Restore Function for People Suffering from Mobility Inhibiting Paralysis
2. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
3. Waters Breaks Ground on New Mass Spectrometry HQ in Wilmslow, UK
4. Therapy Trends: Alzheimer`s Disease - Breaking new ground in disease modification
5. Life Technologies Develops Simplified SAME-DAY STEC Solution for Detecting Multiple Strains of E. coli in Ground Beef
6. Mayor Greg Ballard to Join Roche Diagnostics Leaders at Groundbreaking of New Learning and Development Center
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
10. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
11. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014   Vittamed Corporation , a ... announced today that T. (Teo) Forcht Dagi , ... company,s Board of Directors. " Teo Forcht ... in neurosurgery, medical innovation and venture capital," said Remis ... delighted to add his clinical, strategic, and entrepreneurial expertise to ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
(Date:8/29/2014)... DUBLIN , August 29, 2014 ... management and collaboration software has announced a major new ... services, founded by renowned pathology expert, Dr. Marius ... advance of the 26th European Congress of Pathology which ... in the ExCeL Arena, London ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
... April 14, 2011 Reportlinker.com announces that a new ... Neuropathy Therapy Area Pipeline Report ... Area Pipeline Report contains detailed information on the neuropathy ... status of neuropathy drugs by company and by stage ...
... 14, 2011 Reportlinker.com announces that a new ... Juvenile Rheumatoid Arthritis (JRA) Therapeutics ... http://www.reportlinker.com/p0479828/Juvenile-Rheumatoid-Arthritis-JRA-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html ... and Market Forecasts to 2017 ...
Cached Medicine Technology:Reportlinker Adds Neuropathy Therapy Area Pipeline Report 2Reportlinker Adds Neuropathy Therapy Area Pipeline Report 3Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8
(Date:8/29/2014)... August 29, 2014 Healthpointe is proud ... Rodas. Dr. Rodas will be practicing out of Healthpointe’s ... a member of Healthpointe’s orthopedic team, Dr. ... medicine, and board-certified in occupational medicine. , Among ... as Medical Director of Raytheon, the world-class defense and ...
(Date:8/29/2014)... La Miraca, California (PRWEB) August 29, 2014 ... clinical training to Chapman University Physical Therapy students ... students at Chapman University will be shadowing Healthpointe ... which will allow them to develop clinical experience ... University Physical Therapy students will gain insight into ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Pursuing its ... is set to unveil a stunning new design that ... company figures, the highly notable surrogacy platform has witnessed ... With over 13,000 visitors a month, the FindSurrogateMother.com community ... working toward one common goal — the precious gift ...
(Date:8/29/2014)... based on administering antidepressants for acute and chronic ... are needed to determine whether these drugs should ... basis., Dr. Ian Gilron, a professor and director ... Anesthesiology, and his team of seven researchers reviewed ... antidepressants for pain relief post-surgery would work more ...
(Date:8/29/2014)... Elk Grove Village, IL (PRWEB) August 29, 2014 ... an innovator in hearing wellness solutions, is on its ... Sept. 15-17 at the San Diego Convention Center to ... for those who work in high-noise industrial environments. Etymotic’s ... among the hottest wearable technology devices at the show. ...
Breaking Medicine News(10 mins):Health News:Dr. Anthony G. Rodas Joins Healthpointe Team at LAX Office 2Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Antidepressants show potential for postoperative pain 2Health News:Etymotic’s Safe Listening Earphones and Earplugs Headed For The 2014 NSC Safety Expo 2
... Reporter , TUESDAY, May 15 (HealthDay News) -- With the ... new study on air quality during the 2008 Beijing Olympics ... could lower the risk of heart trouble for many. ... advantage of changes in air quality surrounding the 2008 Olympics, ...
... , TUESDAY, May 15 (HealthDay News) -- The ... were saved between 2004 and 2008 by the U.S. President,s ... The program reduced adults, risk of death from all causes ... Stanford University School of Medicine researchers found. The researchers said ...
... An increasingly common and safer type of surgery for kidney ... sicker and poorer patients who are uninsured or rely on ... new study by researchers at Henry Ford Hospital. The ... portion of a cancerous kidney, leaving the unaffected part to ...
... better mousetrap, a team of Rice University freshmen took a ... children in the developing world. "The goal was to ... could prevent over-hydration and under-hydration," said Melissa Yuan, a member ... a mechanical engineering major. "It,s designed to be used in ...
... Although people with a family history of high blood pressure ... themselves, regular exercise and physical fitness may significantly lower that ... of this study send a very practical message, which is ... which we define as brisk walking for 150 minutes per ...
... Hospital (MGH) researchers suggests that specific populations of tumor cells ... new copies of themselves and grow. In their report ... researchers identify a tumor-propagating cell required for the growth of ... show that another, more-differentiated tumor cell must first travel to ...
Cached Medicine News:Health News:Beijing's Olympic Smog Shows Pollution's Effect on Health 2Health News:Beijing's Olympic Smog Shows Pollution's Effect on Health 3Health News:Safer kidney cancer surgery under-used for poorer, sicker Medicare, Medicaid patients 2Health News:This 'mousetrap' may save lives 2Health News:Fitness Fights High Blood Pressure, Even With Family History 2Health News:All cancer cells are not created equal 2Health News:All cancer cells are not created equal 3
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: